07.06.2022 • News

Sumitomo Chemical to Sell Nufarm Stake

Japan’s Sumitomo Chemical has decided to sell its stake in Australian agrochemicals company Nufarm. Sumitomo’s holding represents 15.9% of Nufarm’s outstanding shares.

The Chuo City-headquartered group explained that the decision was a result of its policy of evaluating every year the medium- to long-term economic rationality and significance of its strategic shareholdings in other companies.

Despite the divestment, Sumitomo said the companies plan to continue their alliance that started more than 12 years ago, adding that they are “currently generating major synergies in the development and sales of agricultural chemicals in over 30 countries around the world.”

Sumitomo bought 20% of Nufarm’s outstanding shares in 2010, beating a rival bid by China’s Sinochem. The Japanese company has since been expanding its global footprint in crop protection, having identified the sector as one of its core businesses in the life sciences field. In 2016, it acquired a majority shareholding in Indian agricultural chemicals company Excel Crop Care and in 2020, it bought four Nufarm subsidiaries in South America.

Headquartered in Melbourne, Nufarm has more than 2,600 staff and posted revenue of AUD 3.2 billion for the fiscal year ended Sep. 30, 2021.

Author: Elaine Burridge, Freelance Journalist

Photo by Henry Be on Unsplash
Photo by Henry Be on Unsplash

Company

Logo:

Sumitomo Chemical


Chuo City, Tokyo
Japan

Company contact







Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.